Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€10.66
03.05.23
€14.47
03.05.24
171.76%
04.05.24

Piper Sandler 
03.05.23 50%
buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€2.30
29.10.23
€4.00
30.06.26
247.39%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.10.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€56.40
20.04.23
€60.11
20.04.24
22.34%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
Alpine Immune Sciences Inc

Start price
Target price
Perf. (%)
€11.50
22.07.23
€15.00
31.08.26
430.43%
12.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
22.07.23 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€34.60
03.04.23
€56.02
03.04.24
87.86%
04.04.24

UBS Group AG 
03.04.23 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€32.60
31.03.23
€45.16
31.03.24
110.12%
01.04.24

HC Wainwright 
31.03.23 50%
buy
Radnet Inc.

Start price
Target price
Perf. (%)
€23.00
31.03.23
€27.57
31.03.24
93.04%
01.04.24

CJS Securities 
31.03.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€52.40
29.03.23
€60.85
29.03.24
22.14%
30.03.24

Needham & Company LLC 
29.03.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€52.40
29.03.23
€58.10
29.03.24
22.14%
30.03.24

Bank of America Co. 
29.03.23 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€6.35
21.03.23
€11.13
21.03.24
122.05%
22.03.24

BTIG Research 
21.03.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€41.80
09.03.23
€54.81
09.03.24
45.22%
10.03.24

JPMorgan Chase & Co. 
09.03.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.92
03.03.23
€19.79
03.03.24
797.26%
04.03.24

Chardan Capital 
03.03.23 50%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€18.54
24.06.23
€27.00
31.12.25
347.68%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€38.80
02.03.23
€45.28
02.03.24
71.39%
03.03.24

The Goldman Sachs Group, Inc. 
02.03.23 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€23.20
02.03.23
€33.06
02.03.24
69.83%
03.03.24

LADENBURG THALM/SH SH 
02.03.23 50%
buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€4.06
02.03.23
€14.17
02.03.24
612.84%
03.03.24

HC Wainwright 
02.03.23 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€23.20
02.03.23
€30.22
02.03.24
69.83%
03.03.24

Needham & Company LLC 
02.03.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€7.79
19.02.24
€6.00
16.05.26
-69.17%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€40.60
01.03.23
€54.33
01.03.24
63.79%
02.03.24

Needham & Company LLC 
01.03.23 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€77.50
28.02.23
€95.04
28.02.24
93.55%
29.02.24

Guggenheim 
28.02.23 50%
buy
Cymabay Therapeutics Inc

Start price
Target price
Perf. (%)
€15.70
12.11.23
€20.00
31.03.26
89.81%
17.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
12.11.23 70%
buy
Kura Oncology Inc

Start price
Target price
Perf. (%)
€17.70
25.01.24
€16.00
31.08.25
9.60%
02.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
25.01.24 70%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€11.01
11.01.23
€6.00
11.01.24
-61.64%
12.01.24

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
11.01.23 50%
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.44
02.12.23
€2.00
02.12.24
-1.29%
05.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Traumtanz 
02.12.23 50%
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.36
29.11.23
€2.00
29.11.24
3.49%
02.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Traumtanz 
29.11.23 50%